Skip to content

Self-Monitoring OCT

Self-Monitoring Optical Coherence Tomography Device for Retinal Telehealth

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07584798
Enrollment
100
Registered
2026-05-13
Start date
2026-09-01
Completion date
2027-12-15
Last updated
2026-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obtaining OCT (Optical Coherence Tomography) Images

Keywords

Ocular diseases, Eye care provider, Self monitoring

Brief summary

The purpose of this research study is to test participants ability to obtain OCT images of the eyes using an OCT device that is comparable to FDA-approved OCT devices on the market, without the help of an eye technician. Patients with ocular diseases often need to come to frequent appointments with an eye care provider for close monitoring and evaluation. Transportation difficulties, other medical problems, and limited appointments slots can make regular follow-up challenging. In addition, the anxiety of permanent vision loss and subjective nature of monitoring symptoms highlight the need for an alternative solution in which patients can self-generate OCT images of the eye for the eye care provider to review.

Interventions

PROCEDURESelf-administered OCT imaging system

Self-administered OCT imaging using modified portable OCT with headrest and software workflow to enable patient self-operation and secure image transfer to a remote reading center.

PROCEDURETechnician-acquired OCT imaging

Technician-acquired OCT obtained using routine clinical equipment during the same visit

Sponsors

Case Western Reserve University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 1\. Provision of signed and dated informed consent. * 2\. Age ≥ 18 years. * 3\. Presenting for care at a University Hospitals Eye Institute clinic * 4\. Willing to complete study questionnaires. * 5\. Scheduled to undergo standard technician-acquired OCT

Exclusion criteria

* 1\. Unable to provide informed consent or, in the judgment of study staff, unable to understand study procedures. * 2\. Unable to cooperate with imaging or maintain stable positioning such that an evaluable OCT scan cannot be obtained (e.g., severe tremor or inability to maintain head position). * 3\. Facial skin condition or open wound at the points of device contact that would make use of the headrest unsafe. * 4\. Acute medical or ocular condition requiring immediate evaluation that, in the PI's judgment, precludes participation at that time. * 5\. Any other condition that, in the opinion of the PI/designee, would place the participant at undue risk or compromise data quality (documented). * 6\. Patients with visual acuity \<20/200. * 7\. Patients with significant media opacities precluding an OCT scan (posterior subcapsular cataract, vitreous hemorrhage, etc), or severe ptosis.

Design outcomes

Primary

MeasureTime frame
Number of inner retinal abnormalities detected as measured by OCT imagesthrough study completion, an average of 1 year
Number of outer retinal abnormalities detected as measured by OCT images.through study completion, an average of 1 year
Sensitivity as measured by OCT images.through study completion, an average of 1 year
Specificity as measured by OCT images.through study completion, an average of 1 year
Positive predictive value (PPV) as measured by OCT images.through study completion, an average of 1 year
Negative predictive value (NPV) as measured by OCT images.through study completion, an average of 1 year

Secondary

MeasureTime frame
Image-quality as recorded by nurse coordinator during patient interaction with the device.through study completion, an average of 1 year
Number of successful completion of self-scans as recorded by nurse coordinator during patient interaction with the device.through study completion, an average of 1 year
Number of repeated attemptsthrough study completion, an average of 1 year

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORWarren Sobol, MD

University Hospitals Cleveland Medical Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 18, 2026